2016
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis
Njei B, Do A, McCarty TR, Fortune BE. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis. Journal Of Clinical Gastroenterology 2016, 50: 871-881. PMID: 27404293, PMCID: PMC5065367, DOI: 10.1097/mcg.0000000000000585.Peer-Reviewed Original ResearchConceptsSevere alcoholic hepatitisAlcoholic hepatitisTrial sequential analysisShort-term mortalityHepatorenal syndromeStudies satisfied inclusion criteriaEffect of corticosteroidsSatisfied inclusion criteriaMortality benefitSignificant morbidityCochrane CollaborationEpidemiologic evidenceCochrane LibraryInclusion criteriaCorticosteroidsHepatitisIndependent reviewersTherapeutic strategiesThird investigatorPentoxifyllinePublication statusPlaceboComprehensive searchMortalityInitial reviewers
2014
Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B, Konjeti VR, Ditah I. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Gastrointestinal Cancer Research : GCR 2014, 7: 49-54. PMID: 24799971, PMCID: PMC4007676.Peer-Reviewed Original ResearchMean overall survivalOverall survivalFL-HCCHepatocellular carcinomaNoncirrhotic patientsSystematic reviewConventional HCCPrognosis of patientsConventional hepatocellular carcinomaFibrolamellar hepatocellular carcinomaRandom-effects modelOutcomes of interestSignificant increaseTypes of HCCLiver transplantationFibrolamellar variantHepatic resectionBetter prognosisClinical courseSurvival outcomesTherapeutic optionsCochrane LibrarySubgroup analysisEgger's testRevMan 5.1